ROCHELLE BARDIS: Open Payments
NPI 1932685856 · PONTE VEDRA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 69 payments from 18 companies in 2025. Trend: 2023 $1,051 · 2024 $1,258 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $344 |
| Amgen Inc. | 13 | $191 |
| Esperion Therapeutics, Inc. | 9 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $103 |
| Alnylam Pharmaceuticals Inc. | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| PFIZER INC. | 3 | $69 |
| Philips North America LLC | 2 | $59 |
| BridgeBio Pharma, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
Products named: LEQVIO, REPATHA, NEXLETOL, JARDIANCE, AMVUTTRA, Kerendia, ECC Solutions, VYNDAQEL.
Industry payments across FL — which companies pay providers there.
